Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 846, Issue 1-2, 2007, Pages 351-354

  Zhu, Hao Jie ^a   Wang, Jun Sheng ^b   Donovan, Jennifer L ^b   DeVane, C Lindsay ^b   Gibson, Bryan B ^b   Markowitz, John S ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

4 (4,5 Diphenyl 1H imidazol 2 yl) benzoyl chloride; Atomoxetine

Indexed keywords

ATOMOXETINE; CONCENTRATION RANGE; FLUORESCENCE DETECTION; LINEAR CALIBRATION CURVES;

AROMATIC COMPOUNDS; BODY FLUIDS; DERIVATIVES; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TRACE ANALYSIS;

DRUG PRODUCTS;

4 (4,5 DIPHENYL 1H IMIDAZOLE 2 YL)BENZOYL CHLORIDE; AMPHETAMINE; ATOMOXETINE; IMIDAZOLE DERIVATIVE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DERIVATIZATION; DRUG DETERMINATION; DRUG STRUCTURE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY;

ADRENERGIC UPTAKE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMIDAZOLES; PROPYLAMINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 33846439404     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.08.019     Document Type: Article

References (15)

1. Faraone S.V., Sergeant J., Gillberg C., and Biederman J. World Psychiatry 2 (2003) 104
2. Patrick K.S., and Markowitz J.S. Hum. Psychopharmacol. 12 (1997) 527
3. Christman A.K., Fermo J.D., and Markowitz J.S. Pharmacotherapy 24 (2004) 1020
4. Sauer J.M., Long A.J., Ring B., Gillespie J.S., Sanburn N.P., DeSante K.A., Petullo D., VandenBranden M.R., Jensen C.B., Wrighton S.A., Smith B.P., Read H.A., and Witcher J.W. J. Pharmacol Exp. Ther. 308 (2004) 410
5. Belle D.J., Ernest C.S., Sauer J.M., Smith B.P., Thomasson H.R., and Witcher J.W. J. Clin. Pharmacol. 42 (2002) 1219
6. Sauer J.M., Ponsler G.D., Mattiuz E.L., Long A.J., Witcher J.W., Thomasson H.R., and Desante K.A. Drug Metab. Dispos. 31 (2003) 98
7. Mullen J.H., Shugert R.L., Ponsler G.D., Li Q., Sundaram B., Coales H.L., Yakupkovic J.E., Lelacheur R.M., Wheeler W.J., Belas F.J., and Sauer J.M. J. Pharm. Biomed. Anal. 38 (2005) 720
8. Witcher J.W., Long A., Smith B., Sauer J.M., Heilgenstein J., Wilens T., Spencer T., and Biederman J. J. Child Adolesc. Psychopharmacol. 13 (2003) 53
9. Mattiuz E.L., Ponsler G.D., Barbuch R.J., Wood P.G., Mullen J.H., Shugert R.L., Li Q., Wheeler W.J., Kuo F., Conrad P.C., and Sauer J.M. Drug Metab. Dispos. 31 (2003) 88
10. Nakashima K., Yamasaki H., Kuroda N., and Akiyama S. Anal. Chim. Acta 303 (1995) 103
11. Kaddoumi A., Kikura-Hanajiri R., and Nakashima K. Biomed. Chromatogr. 18 (2004) 202
12. Kaddoumi A., Nakashima M.N., Maki T., Matsumura Y., Nakamura J., and Nakashima K. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 791 (2003) 291
13. Sun Y., Irie M., Kishikawa N., Wada M., Kuroda N., and Nakashima K. Biomed. Chromatogr. 18 (2004) 501
14. Kuroda N., Kinoshita Y., Sun Y., Wada M., Kishikawa N., Nakashima K., Makino T., and Nakazawa H. J. Pharm. Biomed. Anal. 30 (2003) 1743
15. Sun Y., Nakashima M.N., Takahashi M., Kuroda N., and Nakashima K. Biomed. Chromatogr. 16 (2002) 319